BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morton M, Chambers LM, Costales AB, Chichura A, Gruner M, Horowitz MP, Rose PG, Yao M, Debernardo R, Michener C. Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer. Gynecol Oncol 2021;160:45-50. [PMID: 33067001 DOI: 10.1016/j.ygyno.2020.09.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chambers LM, Yao M, Morton M, Gruner M, Chichura A, Costales AB, Horowitz M, Rose PG, Michener CM, Debernardo R. Assessment of Travel Distance for Hyperthermic Intraperitoneal Chemotherapy in Women with Ovarian Cancer. Gynecologic Oncology Reports 2022. [DOI: 10.1016/j.gore.2022.100951] [Reference Citation Analysis]
2 Chambers LM, Chalif J, Yao M, Chichura A, Morton M, Gruner M, Costales AB, Horowitz M, Chau DB, Vargas R, Rose PG, Michener CM, Debernardo R. Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol 2021;162:368-74. [PMID: 34083027 DOI: 10.1016/j.ygyno.2021.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gruner M, Chambers LM, Yao M, Chichura A, Morton M, Costales AB, Horowitz M, Rose PG, Debernardo R, Michener CM. Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer. Gynecol Oncol 2021;162:645-51. [PMID: 34247768 DOI: 10.1016/j.ygyno.2021.06.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]